Cagrilintide is a long-acting analogue of amylin, a naturally occurring peptide co-secreted with insulin. Optimized for metabolic research, Cagrilintide for sale at the official Peptide Sciences website is highly sought after for studies involving obesity, Type 2 diabetes, and the synergistic effects of combination therapy with GLP-1 agonists like Semaglutide.